Telix Pharmaceuticals (TLX.AU) Q3 2026 Earnings

19AugConfirmed
Q1 2025
Q3 2025
Q1 2026
Q3 2026
-0.02
0.06
0.13
0.21

Details

Expected EPS
0.06272663485826552
Actual EPS
0.15071568902610163
Surprise EPS
0.09
Surprise Percent
+140.27%

Description

Telix Pharmaceuticals (TLX.AU) has reported earnings of 0.15071568902610163 per share for Q3 2026.

0 Comments

Share your thoughts